Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

Bluebird Bio & Novo Partner for Haemophilia Genome Editing (2019-10-09)
bluebird bio, Inc. (Nasdaq: BLUE) and Novo Nordisk A/S (NVO) today announced that they have entered into a research collaboration to jointly develop next-generation in vivo genome editing treatments for genetic diseases, including haemophilia. During the three-year...
Arix Co-leads €20m Series A Round of STipe Therapeutics (2019-09-30)
> Arix co-leads EUR 20 million Series A investment round in new portfolio company STipe > Arix further strengthens position in oncology; investment in STipe increases oncology portfolio to six companies > Dr Christian Schetter, Entrepreneur in Residence at Ar...
Lundbeck & Takeda: Approval of Trintellix for MDD in Japan (2019-09-20)
> New treatment option with a new pharmacological profile for adult patients with Major Depressive Disorder (MDD) and depressed state in Japan > Phase III clinical trial in Japan with 493 adults with major depressive disorder show that the vortioxetine groups de...
Themis Bioscience Raises €40m Series D Financing Round (2019-09-18)
— Themis well-funded through completion of Chikungunya Phase 3 program — Themis announced today the closing of a Series D financing round totaling EUR 40 million (USD 44 million). The round was co-led by new investors, Farallon Capital and Hadean Ventures. MSD...
Lundbeck to Acquire Alder Bio for up to $1.95b Net of Cash (2019-09-16)
> Enhances Lundbeck’s leading portfolio of brain disease therapies with Alder’s highly complementary intravenous (IV) therapy for migraine prevention, eptinezumab > Eptinezumab is an investigational monoclonal antibody (mAb) for migraine prevention targeting the...
Lytix Biopharma AS Promotes Øystein Rekdal to CEO (2019-09-12)
Dr. Edwin Klumper has announced that he will step down from his role as CEO of Lytix Biopharma because of early retirement. The board has decided to promote Head of R&D Øystein Rekdal to the position of CEO from September 11, 2019. Dr. Klumper has agreed to assist ...
Genmab & Tempus: Strategic Drug Discovery Collaboration (2019-09-09)
Genmab and Tempus sign agreement to research and develop novel targets Genmab A/S (Nasdaq: GMAB) announced today that it has entered into a strategic collaboration agreement with Tempus, a privately-owned technology company advancing precision medicine through...
Sigrid Therapeutics AB Closes $1.6m Financing Round (2019-09-05)
Sigrid Therapeutics AB, an innovative technology company developing a new class of products to improve human health, including type 2 diabetes, today announces an equity financing round of USD 1.6M. The two times oversubscribed financing round was led by Joyance Pa...
Curetis & OpGen Announce Reverse Merger (2019-09-04)
> Combined company creates a commercial-stage, transatlantic diagnostics company focusing on data-driven solutions for molecular microbiology > Combined company to be headquartered in Gaithersburg, MD, USA > Transaction is supported by the boards of OpGen and...
Boehringer/Zealand Advance GLP-1/Glucagon Agonist to Phase 2 (2019-09-03)
> The dual acting GLP-1/glucagon peptide BI 456906 is a part of Boehringer Ingelheim’s pipeline portfolio in obesity and diabetes > The Phase 2 trial for BI 456906 is expected to be initiated in late 2019 and will trigger a EUR 20 million milestone payment to Ze...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)